Intravenous Immunoglobulin (IVIg) Market Overview
Market Research Future (MRFR) studied the global intravenous immunoglobulin (IVIg) market 2020 along the analysis tenure till 2027. By 2027, the intravenous immunoglobulin (IVIg) market is likely to rise at 6.30% CAGR. On the conclusion of the study period, the intravenous immunoglobulin (IVIg) market is expected to touch USD 10,485.86 Mn.
The expansion of hemophilic patient pool and rise in adoption of intravenous immunoglobulin treatment are observed to bolster the market growth. The availability of modern technologies for the production of immunoglobulin solutions and their purification can impact the IVIg market expansion. However, strict government norms regarding intravenous immunoglobulin products manufacturing and launch, and increase in awareness about side effects of immunoglobin treatment can hinder the market rise. On the contrary, the high rate of adoption of IVIg for treating diseases, such as; CIDP and hypogammaglobulinemia among others can counter the market slow-down due to surfacing challenges.
Get customized Sample with complete Toc, Inclusive of COVID-19 Industry Analysis @ https://www.marketresearchfuture.com/sample_request/3137
Intravenous Immunoglobulin (IVIg) Market Segmentation
The segment study of the global intravenous immunoglobulin (IVIg) market is based on application and on type.
The type-based segments of the global intravenous immunoglobulin market are IgA, IgG, IgD, and IgE. The sub segments of the IgA market are IgA2 and IgA1. The high success rate of IgA treatment can promote expansion of the market. The expansion of the IgA segment can be attribute to the surge in number of clinical trials and intravenous product approvals for latest clinical applications. A gradual increase in healthcare expenditure and increase in awareness about autoimmune diseases that facilitate the demand for IVIG therapies to treat primary and acquired immunodeficiency diseases can bolster the IgA segment growth. Sedentary lifestyle initiating disorders, such as; antibody deficiency and obesity are creating the need for immunology treatment that can drive the market growth.
The application-based segments of the global intravenous immunoglobulin market are CIDP, Hypogammaglobulinemia, Miller Fisher syndrome, Guillain-Barre syndrome, Multifocal Motor Neuropathy, Myasthenia Gravis, Immunodeficiency diseases, acute motor-sensory axonal neuropathy, severe combined immunodeficiency, common variable immunodeficiency, Primary Humoral Immunodeficiency, Guillain-Barre syndrome, Kawasaki disease, ITP, acute motor-sensory axonal neuropathy. The sub-segments of the CIDP segment are progressive, monophasic, and recurrent. The sub-segments of the hypogammaglobulinemia segments are AGM3, AGM1, AGM2, AGM5, AGM4, and AGM6. Common variable immunodeficiency (CVID), X-linked agammaglobulinemia (XLA), and severe combined immunodeficiency are sub-segments of the immunodeficiency diseases segment. The primary humoral immunodeficiency segments comprise of T cell deficiencies, B cell (antibody) deficiencies, Defective phagocytes, Combination B and T cell deficiencies, Unknown (idiopathic), and Complement deficiencies. The myasthenia gravis segment comprises of ocular myasthenia gravis, myasthenia gravis, congenital myasthenia gravis, and transient neonatal myasthenia gravis. The Guillain-Barre syndrome segment comprise of Acute inflammatory demyelinating polyradiculoneuropathy (AIDP), Acute motor axonal neuropathy (AMAN), Miller Fisher syndrome (MFS), and acute motor-sensory axonal neuropathy (AMSAN). The ITP segment comprises of chronic and acute.
Intravenous Immunoglobulin (IVIg) Market Regional Analysis
In North America, the intervenors immunoglobulin market is expected to acquire financial gain due to the increase in awareness about different products used in the treatment of different immunodeficiency diseases. The growing inclination of physicians towards different therapies and rise in healthcare expenses can be attributed to the growth of North America market.
Changes in lifestyle and expansion of ageing population are expected to contribute to the rise of intravenous immunoglobin industry in the years to come. In addition, the surge in incidences of PID, chronic disorder, and autoimmune diseases can add to the regional market upsurge.
In Asia Pacific, the intravenous immunoglobin market is expected to exhibit high CAGR and hold lucrative growth scopes over the review period. The rise in awareness about potential opportunities for the immunoglobulin-based therapies in the region and easy accessibility of treatment for primary immune deficiencies can benefit the regional market in the near future.
Increase in healthcare spending and growing preference for IV immunoglobulin treatment can favor the market in MEA. The adoption of different medical business models, increase in cases of immune disorders, and surge in awareness about intravenous and subcutaneous immunoglobulin therapies can contribute to the rise of the regional market.
Intravenous Immunoglobulin (IVIg) Market Key Players
ABEONA THERAPEUTICS (US), Biotest AG.(Germany), Baxter (US), China Biologic Products, Inc. (China), BDI Pharma (US), CSL Behring (US), Kedrion S.p.A (us), Grifols Inc. (Spain), Octapharma (Switzerland), and Shire (Republic of Ireland) are some reputed players in the global intravenous immunoglobulin (IVIg) market that are profiled by MRFR. Key players are focusing on their global reputation by boosting their market penetration strategies, and other related details are discussed in the report.
Table Of Content
1. Report Prologue
2.2 Scope Of The Study
2.2.1 Research Objective
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.4 Mega Trends
4.5 Macroeconomic Indicators
5. Market Factor Analysis
Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @ https://www.marketresearchfuture.com/reports/intravenous-immunoglobulin-market-3137
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
+1 646 845 9312
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.